A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer

Overview of attention for article published in Clinical Cancer Research, March 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent: 30 patents

Readers on

mendeley: 102 Mendeley
citeulike: 4 CiteULike

So far, Altmetric has seen 30 patents that reference this research output.

IN VITRO METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM BREAST CANCER AND/OR FOR…

Application WO-2026153944-A1

World Intellectual Property Organisation (WIPO)

23 Jul 2026

IN VITRO METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM BREAST CANCER AND/OR FOR…

Application EP-4775991-A1

European Patent Office

15 Jul 2026

Method of using biomarkers and clinical variables for predicting chemotherapy benefit

Grant US-12180551-B2

United States of America

31 Dec 2024

Method for breast cancer recurrence prediction under endocrine treatment

Grant US-11913078-B2

United States of America

27 Feb 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 26 additional patents.